Advanced search×

Increased aromatase expression in the hippocampus of spontaneously hypertensive rats: effects of estradiol administration

L Pietranera, MJ Bellini, MA Arévalo, R Goya, ME Brocca, LM Garcia-Segura, and AF De Nicola

Neuroscience (2011) PMID 21115103

There is high incidence of hippocampal abnormalities in spontaneously hypertensive rats (SHR), including decreased neurogenesis in the dentate gyrus, astrogliosis, low expression of brain derived neurotrophic factor and decreased neuronal density in the hilar region, respect of normotensive Wistar Kyoto rats (WKY). Estradiol treatment given for 2 weeks normalized the faulty hippocampal parameters of SHR, without having effects on WKY rats. The present work studied the potential role of local estrogen biosynthesis in the hippocampus of SHR and WKY, by measuring the expression of aromatase, the key enzyme responsible for estrogen biosynthesis and involved in neuroprotection. We used 4 month old male SHR and WKY, half of which received a single sc pellet of 12 mg estradiol benzoate and the remaining half a cholesterol implant. Hippocampi were dissected and processed for aromatase mRNA expression using real time PCR. A second batch of animals was processed for aromatase and glial fibrillary acidic protein (GFAP) immunocytochemistry. Basal level of aromatase mRNA was higher in SHR respect of WKY. Following estradiol treatment, aromatase mRNA was further increased in the SHR group only. In the hilus of the dentate gyrus of cholesterol-implanted SHR, we found aromatase immunoreactive cell processes and fibers more strongly stained respect of WKY rats. Estradiol treatment of SHR further increased the length of immunoreactive processes and fibers in the hilar region and also increased aromatase immunoreactivity in the CA1 but not the CA3 pyramidal cell region. WKY rats were spared from the estradiol effect. Double-labelling experiments showed that aromatase+ processes and fibers of the hilus of SHR-treated rats did no colocalize with GFAP+ astrocyte cell bodies or processes. In conclusion, basal and estradiol-stimulated aromatase expression was enhanced in hypertensive rat hippocampus. A combination of exogenous estrogens and those locally synthesized may better alleviate hypertensive encephalopathy.

DOI: 10.1016/j.neuroscience.2010.11.044
Version: za2963e q8za8 q8zb8 q8zc0 q8zd7 q8zea q8zf7 q8zg0

Similar articles you may find interesting…

  1. Why does oestrogen-only hormone therapy have such a small impact on breast cancer risk? A hypothesis.
    John A JA Eden

    Gynecol Endocrinol 27(3):170-5 (2011) PMID 20500114

    There seems to be irrefutable evidence that oestrogen is involved in the pathogenesis of breast cancer. The disease mostly affects women and the epidemiology of breast cancer relates to reproductive markers such as pregnancy, age at menarche and age of menopause. Most breast cancers elaborate oestro...
  2. The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer.
    G J GJ van Londen, S S Perera, ... S L SL Greenspan

    Breast Cancer Res Treat 125(2):441-6 (2011) PMID 21046232

    Aromatase inhibitors (AIs) have become the standard adjuvant therapy of postmenopausal breast cancer survivors. AIs induce a reduction of bioavailable estrogens by inhibiting aromatase, which would be expected to induce alterations in body composition, more extensive than induced by...
  3. Efficient expression of human aromatase (CYP19) in E. coli.
    Norio Kagawa

    Methods Mol Biol (2011) PMID 21125383

    We have developed the expression system of human aromatase in E. coli. The human aromatase has two major forms from its genetic polymorphism, arginine (264R) and cysteine (264C) at the amino acid position 264. Although there is only one amino acid difference between the two forms of aromatase, the 2...